Abstract
Background
Research indicates that successful migraine assessment and treatment depends on information obtained during patient and healthcare professional (HCP) discussions. However, no studies outline how migraine is actually discussed during clinical encounters.
Objective
Record naturally occurring HCP–migraineur interactions, analyzing frequency and impairment assessment, and preventive treatment discussions.
Design
HCPs seeing high volumes of migraineurs were recruited for a communication study. Patients likely to discuss migraine were recruited immediately before their normally scheduled appointment and, once consented, were audio- and video-recorded without a researcher present. Separate post-visit interviews were conducted with patients and HCPs. All interactions were transcribed.
Participants
Sixty patients (83% female; mean age 41.7) were analyzed. Patients were diagnosed with migraine 14 years and experienced 5 per month, on average.
Approach
Transcripts were analyzed using sociolinguistic techniques such as number and type of questions asked and post-visit alignment on migraine frequency and impairment. American Migraine Prevalence and Prevention Study guidelines were utilized.
Results
Ninety-one percent of HCP-initiated, migraine-specific questions were closed-ended/short answer; assessments focused on frequency and did not focus on attention on impairment. Open-ended questions in patient post-visit interviews yielded robust impairment-related information. Post-visit, 55% of HCP–patient pairs were misaligned regarding frequency; 51% on impairment. Of the 20 (33%) patients who were preventive medication candidates, 80% did not receive it and 50% of their visits lacked discussion of prevention.
Conclusions
Sociolinguistic analysis revealed that HCPs often used narrowly focused, closed-ended questions and were often unaware of how migraine affected patients’ lives as a result. It is recommended that HCPs assess impairment using open-ended questions in combination with the ask-tell-ask technique.
Similar content being viewed by others
References
Lipton RB, Diamond S, Reed M, Diamond ML, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache. 2001;4(17)638–45.
Lipton RB, Stewart RF. Acute migraine therapy: do doctors understand what patients with migraine want from therapy? Headache. 1999;39(Suppl 2)S20–6.
Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of health care use. Neurology. 2002;58(6)885–94.
Barrier PA, Li JT, Jensen NM. Two words to improve physician–patient communication: what else? Mayo Clin Proc. 2003;78(2)211–4.
Mueller PS, Barrier PA, Call TG, Duncan AK, Hurley DL, Multari A, Rabatin JT, Li JT. Views of new internal medicine faculty of their preparedness and competence in physician–patient communication. BMC Med Educ. 2006;6:30.
Silberstein S. Practice parameters: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 2000;55:754–62.
Taylor F, Hutchinson S, Cady R, Harris L, Graff-Radford S. Diagnosis and management of migraine. Strategies to improve headache diagnosis and treatment in family practice. J Fam Pract. 2004;Suppl:S3–4.
Cottrell CK, Drew JB, Waller SE, Holroyd KA, Brose JA, O’Donnell FJ. Perceptions and needs of patients with migraines: a focus group study. J Fam Pract. 2002;5(12)142–7.
Dodick D. Patient perceptions and treatment preferences in migraine management. CNS Drugs. 2002;16(Suppl 1)19–24.
Levin M. Migraine headache: accurate diagnosis, targeted treatment. Adv Stud Med. 2004;44208–9.
Lipton RB, Bigal ME, Stewart WF. Clinical trials of acute treatments for migraine including multiple attack studies of pain, disability, and health-related quality of life. Neurology. 2005;12Suppl 4S50–8.
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden and need for preventive therapy. Neurology. 2007;68(5)343–9.
Roter D, Hall J. Doctors Talking with Patients/Patients Talking with Doctors: Improving Communication in Medical Visits. Westport: Auburn House; 1992.
Becker WJ. Communication with the migraine patient. Can J Neurol Sci. 2002;29(Suppl 2)1–2.
Edmeads J. Communication issues in migraine diagnosis. Can J Neurol Sci. 2002;29(Suppl 2):S8–10.
Franks P, Jerant AF, Fiscella K, Shields CG, Tancredi DJ, Epstein RM. Studying physician effects on patient outcomes: physician interactional style and performance on quality of care indicators. Soc Sci Med. 2006;6(2):2422–32.
Robinson G. Effective doctor patient communication: building bridges and bridging barriers. Can J Neurol Sci. 2002;29(Suppl 2):S30–2.
Sheftell FD. Communicating the right therapy for the right patient at the right time: acute therapy. Can J Neurol Sci. 2002;29(Suppl 2):S33–9.
Baos V, Ester F, Castellanos A, Nocea G, Caloto MT, Gerth WC. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes. Int J Clin Pract. 2005;59(3):281–6.
Cady RK, Borchert LD, Spalding W, Hart CC, Sheftell FD. Simple and efficient recognition of migraine with 3-question headache screen. Headache. 2004;44:323–27.
Lipton RB, Bigal ME, Amatniek JC, Stewart WF. Tools for diagnosing migraine and measuring its severity. Headache. 2004;44:387–98.
Lipton RB, Dodick DD, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, et al.. A self-administered screener for migraine in primary care. The ID Migraineä validation study. Neurology. 2003;61:375–82.
Marcus DA, Kapelewski C, Jacob RG, Rudy TE, Furman JM. Validation of a brief nurse-administered migraine assessment tool. Headache. 2004;44:328–32.
Stewart WF, Lipton RB. Need for care and perceptions of MIDAS among headache sufferers study. CNS Drugs. 2002;16(Suppl 1):S5–11.
Holmes WF, MacGregor EA, Sawyer JPC, Lipton RB. Information about migraine disability influences physicians’ perception of illness severity and treatment needs. Headache. 2001;41(4):343–50.
Gumperz JJ. Discourse Strategies. Cambridge: Cambridge University Press; 1982.
Gumperz JJ. On Interactional Sociolinguistic Method. In: Sarangi S, Roberts C, eds. Talk, work and institutional order. Discourse in medical, mediation and management settings. Berlin: Mouton de Gruyter; 1999:453–71.
Hamilton HE. Symptoms and signs in particular. The influence of the medical condition on the shape of physician–patient talk. Commun Med. 2004;1(1):59–70.
Hamilton HE, Nelson M, Martin P, Cotler SJ. Provider–patient in-office discussions of response to hepatitis C antiviral therapy and impact on patient comprehension. Clin Gastroenterol Hepatol. 2006;44507–13.
Aranguri C, Davidson B, Ramirez R. Patterns of communication through interpreters: a detailed sociolinguistic analysis. J Gen Intern Med. 2006;21:623–29.
Davidson B, Vogel V, Wickerham L. Oncologist–patient discussion of adjuvant hormonal therapy in breast cancer: results of a linguistic study focusing on adherence and persistence to therapy. J Support Oncol. 2007;5:36–40.
Davidson B, Blum D, Cella D, Hamilton H, Nail L, Waltzman R. Communicating about chemotherapy-induced anemia. J Support Oncol. 2007;5:36–40. 46.
Blumenfeld A, Tischio M. Center of excellence for headache care: group model at Kaiser Permanente. Headache. 2003;43(5):431–40.
Speer S, Hutchby I. From ethics to analytics: aspects of participants’ orientations to the presence and relevance of recording devices. Sociology. 2003;37(2):315–37.
Dyche L, Swiderski D. The effects of physician solicitation approaches on ability to identify patient concerns. J Gen Intern Med. 2005;20(3):267–70.
Frankel R, Altschuler A, George S, Kinsman J, Jimison H, Robertson NR, Hsu J. Effects of exam-room computing on clinician–patient communication: a longitudinal qualitative study. J Gen Intern Med. 2005;20(8):677–82.
Suchman AL, Markakis K, Beckman HB, Frankel R. A model of empathic communication in the medical interview. JAMA. 1997;277(8):678–82.
Lipton RB, Diamond M, Freitag D, Bigal M, Stewart WF, Reed ML. Migraine prevention patterns in a community sample: results from the American Migraine Prevalence and Prevention (AMPP) Study. Poster presented at the American Headache Society’s 47th Annual Scientific Meeting. June 2005. Philadelphia, PA.
Berry DL, Wilkie DJ, Thomas CR, Fortner P. Clinicians communicating with patients experiencing cancer pain. Cancer Invest. 2003;21(3):374–81.
Braddock CH, Synder L. The doctor will see you shortly. The ethical significance of time for the patient–physician relationship. J Gen Intern Med. 2005;20(11):1057–62.
Dowson AJ. Assessing the impact of migraine. Curr Med Res Opin. 2001;17(4):298–309.
Dueland AN, Leira R, Cabelli S. The impact of migraine on psychological well-being of young women and their communication with physicians about migraine. Curr Med Res Opin. 2005;21(8):1297–305.
Lipton RB, Bigal ME, Rush SR, Yenkosky JP, Liberman JN, Bartleson JD, et al.. Migraine practice patterns among neurologists. Neurology. 2004;62:1926–31.
Robinson JD, Heritage J. Physicians’ opening questions and patients’ satisfaction. Patient Educ Couns. 2006;60(3):279–85.
Greer J, Halgin R. Predictors of physician–patient agreement on symptom etiology in primary care. Psychosom Med. 2006;68(2):277–82.
Hagihara A, Odamaki M, Nobutomo K, Tarumi K. Physician and patient perceptions of the physician explanations in medical encounters. J Health Psychol. 2006;11(1):91–105.
Abdel-Tawab N, Roter D. The relevance of client-centered communication to family planning settings in developing countries: lessons from the Egyptian experience. Soc Sci Med. 2002;54(9):1357–68.
Headache Study Group. Predictors of outcome in headache patients presenting to family physicians—a one year prospective study. Headache. 1986;26:285–94.
Hahn SR. Communication in the Care of the Headache Patient. In: Silberstein S, Lipton RB, Dodick D, eds. Wolff's Headache and Other Head Pain. Eighth ed. New York: Oxford University Press; 2007:805–24.
Frymoyer JW, Frymoyer NP. Physician–patient communication: a lost art? J Am Acad Orthop Surg. 2002;10(2):95–105.
Ishikawa H, Takayama T, Yamazaki Y, Seki Y, Katsumata N. Physician–patient communication and patient satisfaction in Japanese cancer consultations. Soc Sci Med. 2002;55(2):301–11.
Martin LR, Jahng KH, Golin CE, DiMatteo MR. Physician facilitation of patient involvement in care: correspondence between patient and observer reports. Behav Med. 2003;28(4):159–64.
Roter DL, Larson S, Shinitzky H, Chernoff R, Serwint JR, Adamo G, Wissow L. Use of an innovative video feedback technique to enhance communication skills training. Med Educ. 2004;38(2):145–47.
Back AL, Arnold RM, Baile WF, Tulsky JA, Fryer-Edwards K. Approaching difficult communication tasks in oncology. CA Cancer J Clin. 2005;55(3):164–77.
Boyle D, Dwinnell B, Platt F. Invite, listen, and summarize: a patient-centered communication technique. Acad Med. 2005;80(1):29–32.
Lipton RB, Stewart WF, Simon D. Medical consultation for migraine: results from the American Migraine Study. Headache. 1998;38:87–96.
Rao JK, Anderson LA, Inui TS, Frankel RM. Communication interventions make a difference in conversations between physicians and patients: a systematic review of the evidence. Medical Care. 2007;45(4):340–9.
Acknowledgements
The authors wish to thank Ortho-McNeil Neurologics and Corey Eagan of MBS/Vox.
Conflict of interest summary
Dr. Lipton has received grants from Allergan, Advanced Bionics Corporation, GlaxoSmithKline, Merck & Co., Inc., Neuralieve, Ortho-McNeil, Pfizer, Proethics Ltd., and St. Jude Children’s Research Hospital. He has consulted for Allergan, Ortho-McNeil, and Pfizer.
Dr. Hahn has received honoraria from GlaxoSmithKline, Eli Lilly and Company, Ortho-McNeil, and Pfizer. He has consulted with GlaxoSmithKline, Eli Lilly and Company, Ortho-McNeil, and Pfizer.
Dr. Cady is the owner of Banyan Group, Inc., a medical clinic, clinical research facility, and meeting planning division that conducts medical education. Banyan Group has received grants from Abbott Laboratories, Advanced Bionics Corporation, Alizyme, Allergan, Alexza Pharmaceuticals, Aradgim Corporation, CAPNIA, Incorporated, Cipher Pharmaceuticals, Inc., Eisai, Inc., Endo Pharmaceuticals, GelStat Corp., GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MAP Pharmaceuticals, Matrixx Initiatives, Inc., Merck & Co., Neuralieve, Novartis, Ortho-McNeil, Pfizer, Pozen Pharmaceutical Development Company, SCHWARZ Pharma AG, Torrey Pines, and Vernalis. He has received honoraria from ABT Associates, Allergan, Aradgim Corp., Atrix, Capnia, Endo, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MedPointe Pharmaceuticals, Merck & Co., Inc., and Winston Laboratories, Inc. He has consulted for ABT Associates, Allergan, Aradgim Corp., Atrix, CAPNIA Incorporated, Endo Pharmaceuticals, GlaxoSmithKline, Jazz Pharmaceuticals, Johnson & Johnson, MedPointe Pharmaceuticals, Merck & Co., Inc., and Winston Laboratories, Inc.
Dr. Brandes has received clinical or educational support from Advanced Bionics Corporation, Allergan, AstraZeneca, Bristol-Myers Squibb, Elan Pharmaceuticals, Endo Pharmaceuticals, GlaxoSmithKline, Johnson & Johnson, Merck & Co., Inc., Novartis, Ortho-McNeil, Pfizer, Pozen Pharmaceutical Development Company, Sanofi-Aventis, UCB, Vernalis, and Winston Laboratories, Inc. She is on the Speakers’ Bureau/Advisory Board for Allergan, AstraZeneca, Endo Pharmaceuticals, GlaxoSmithKline, Merck, Ortho-McNeil, and Pfizer.
Ms. Simons has no conflicts to declare.
Dr. Bain has no conflicts to declare.
Ms. Nelson has no conflicts to declare.
Author information
Authors and Affiliations
Corresponding author
Additional information
Study design and subsequent publication were a joint effort by MBS/Vox, academic co-authors, and Ortho-McNeil Neurologics. All data collection and analysis was conducted by MBS/Vox. Funding was provided by Ortho-McNeil Neurologics.
Rights and permissions
About this article
Cite this article
Lipton, R.B., Hahn, S.R., Cady, R.K. et al. In-office Discussions of Migraine: Results from the American Migraine Communication Study. J GEN INTERN MED 23, 1145–1151 (2008). https://doi.org/10.1007/s11606-008-0591-3
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11606-008-0591-3